Thermo Fisher Scientific to acquire Clario Holdings for $8.875B

Thermo Fisher Scientific agreed to acquire Clario Holdings, a provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for $8.875 billion in cash at close plus potential earnout payments.

“Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc.”ir.thermofisher.com

• 1 source
• ir.thermofisher.comThermo Fisher Scientific Inc. - Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical InsightsOct 29, 2025

Summarized from public sources; check the original articles before acting on it.